{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"31.000","rs_stock_flag":false,"fiscal_year_end":"","hist_closedate":"","replication_method":null,"amt_os":"160,701,996","primaryexch":"HKEX","ric":"2575.HK","product_subtype":null,"db_updatetime":"15 Oct 2025 09:36","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BTXY8J6","am":"344.65","iv":"","ew_strike":"","as":"28.820","geographic_focus":null,"incorpin":"PRC","etp_baseCur":null,"ew_amt_os":"","bd":"28.720","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-10-15 01:36:30.0","lo52":"","shares_issued_date":"15 Oct 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Xu Yanjun","underlying_ric":"2575.HK","hi52":"","issuer_name":"Xuanzhu Biopharmaceutical Co., Ltd. - B - H Shares","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"15 Oct 2025 10:18","aum_date":"","lo":"27.000","mkt_cap":"4.62","f_aum_hkd":null,"ew_sub_per_to":"","ls":"28.800","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"0","aum":"","issued_shares_class_B":null,"vo":"11.68","secondary_listing_flag":false,"listing_date":"15 Oct 2025","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Xuanzhu Biopharmaceutical Co., Ltd. - B - H Shares","nm_s":"XUANZHUBIO-B","sym":"2575","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"Xuanzhu Biopharmaceutical Co Ltd is a China-based company principally engaged in biopharmaceutical business. The Company is primarily engaged in business of research and development, manufacturing and commercialization of innovative drugs, focusing on a number of therapeutic areas such as digestion, oncology and non-alcoholic steatohepatitis (NASH). The Companyâ€™s main products include KBP-3571, XZP-3287 and XZP-3621. The Company mainly conducts its businesses in the domestic market and overseas markets.","op":"29.460","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"203C507, Beijing-Tianjin-Hebei<br/>Collaborative Inno Demo Park<br/>769 Taihang St, Hi-Tech Dist<br/>Shijiazhuang, Hebei Prov, PRC","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"","isin":"CNE1000074Q1","moneyness":""}},"qid":"1760495611676"}
